IGF1 and diabetes mellitus: On the other hand, patients with SG tumors with low SSTR2 expressivity and hyper-intense T2-weighted MRI signal would benefit from DA therapy when there is only modest elevation of IGF-1, or PEG in the setting of significantly elevated IGF-1 levels, uncontrolled diabetes, and when tumor location and size is not a concern [28].